Scoop has an Ethical Paywall
Licence needed for work use Start Free Trial
 

CLL Advocates NZ - Latest News [Page 1]

Funding Of Chronic Lymphocytic Leukaemia With Ibrutinib + Venetoclax And Obinutuzumab + Venetoclax

Wednesday, 18 February 2026, 1:51 pm | CLL Advocates NZ

CLL Advocates NZ will continue to fight for better treatments for CLL patients. CLL is one of the most common blood cancers, with an increasing incidence in the aging population. More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL